Everest Medicines Adds Two Drugs to China's Reimbursement ListTradingView·Nov 16, 2026 at 11:48 AM01952-2.24%
Weekly Recap | EVEREST MED -2.44%, consensus target above spotWeekly Review·Nov 14, 2026 at 05:14 AM01952-2.24%
BOCOM International Holdings Company Sticks to Their Buy Rating for Everest Medicines Ltd. (1952)Tip Ranks·Nov 13, 2026 at 12:25 PM01952-2.24%
What Investors Overlooked Before Everest Medicines SlidSimplywall·Nov 13, 2026 at 06:47 AM01952-2.24%
China Approves New 100 mg XERAVA® Strength for Adult cIAITip Ranks·Nov 12, 2026 at 11:26 PM01952-2.24%
Weekly Recap | EVEREST MED +0.3%, most brokers rate it buyWeekly Review·Nov 7, 2026 at 05:36 AM01952-2.24%
Everest Medicines Seeks Shareholder Approval for Strategic Cooperation Agreement With HastenPUBT·Oct 30, 2026 at 09:08 AM01952-2.24%